Nuwellis (NUWE) Change in Acquisitions & Divestments (2022)

Nuwellis (NUWE) reported Change in Acquisitions & Divestments of $14.8 million for Q4 2022.

Nuwellis (NUWE) Change in Acquisitions & Divestments (2022) Analysis & Trends

Nuwellis has reported Change in Acquisitions & Divestments for 1 years, with the latest figure at $14.8 million in Q4 2022.

  • For the quarter ending Q4 2022, Change in Acquisitions & Divestments changed N/A year-over-year to $14.8 million; the trailing twelve-month figure through Sep 2024 stood at $14.8 million (changed N/A YoY), and the FY2023 full-year result was $578000.0, down 96.11% from the prior year.
  • Change in Acquisitions & Divestments for Q4 2022 stood at $14.8 million.
  • The five-year high for Change in Acquisitions & Divestments was $14.8 million in Q4 2022, with the low at $14.8 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 14.85 Mn
Dec 31, 2022 14.85 Mn